• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔黏膜下纤维性变的药物治疗:最新进展。

Drug treatment for oral submucous fibrosis: an update.

机构信息

Department of Pharmacy, Changsha Stomatological Hospital, Changsha, 410006, China.

School of Stomatology, Hunan University of Chinese Medicine, Changsha, 410006, China.

出版信息

BMC Oral Health. 2023 Oct 12;23(1):748. doi: 10.1186/s12903-023-03488-9.

DOI:10.1186/s12903-023-03488-9
PMID:37828490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10568776/
Abstract

OBJECTIVE

The aim of this review is to evaluate the different medicinal interventions available for the management of oral submucous fibrosis (OSF).

MATERIALS AND METHODS

We conducted a comprehensive electronic search on PubMed, Web of Science, and Cochrane Library databases for articles related to OSF patients treated with medications from December 2011 to September 2022. GRADE system was used to evaluate the evidence quality. The reporting of the systematic review is in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol. The main outcomes were the improvement of maximum mouth opening, burning sensation, cheek flexibility, and tongue protrusion.

RESULTS

Twenty-nine randomized controlled trials (RCTs), five clinical trials (CCTs) were included, and the use of drugs for OSF treatment were evaluated. Drugs like steroids, hyaluronidase, pentoxifylline, lycopene, curcumin, dpirulina, aloe vera, omega3, oxitard, allicin, colchicine have been used. It was found that drugs with evidence high quality were salvia miltiorrhiza combined with triamcinolone acetonide, lycopene, pentoxifylline, curcumin, and aloe vera, and those with evidence moderate quality were allicin, colchicine, omega 3, and oxitard.

CONCLUSION

Based on the results of our comprehensive analysis, for long-term treatment, we found lycopene with low side effects, whereas for relieving the symptoms of severe burning sensation, aloe vera is the most effective. Although the recent review has made some progress, drug therapy for OSF remains unclear, and more high-quality RCTs are needed to identify better treatments for OSF.

摘要

目的

本综述旨在评估治疗口腔黏膜下纤维性变(OSF)的各种医学干预措施。

材料和方法

我们对 2011 年 12 月至 2022 年 9 月期间在 PubMed、Web of Science 和 Cochrane 图书馆数据库中与接受药物治疗的 OSF 患者相关的文章进行了全面的电子搜索。使用 GRADE 系统评估证据质量。系统评价的报告符合系统评价和荟萃分析的首选报告项目(PRISMA)协议。主要结局是改善最大张口度、烧灼感、颊部灵活性和舌伸出。

结果

共纳入 29 项随机对照试验(RCT)和 5 项临床试验(CCT),评估了药物治疗 OSF 的效果。研究中使用了类固醇、透明质酸酶、己酮可可碱、番茄红素、姜黄素、藻蓝蛋白、芦荟、欧米伽 3、奥昔他汀、大蒜素、秋水仙碱等药物。研究发现,丹参酮联合曲安奈德、番茄红素、己酮可可碱、姜黄素和芦荟等药物具有高质量证据,大蒜素、秋水仙碱、欧米伽 3 和奥昔他汀等药物具有中等质量证据。

结论

根据我们全面分析的结果,对于长期治疗,我们发现低副作用的番茄红素,而对于缓解严重烧灼感的症状,芦荟是最有效的。尽管最近的综述取得了一些进展,但 OSF 的药物治疗仍不清楚,需要更多高质量的 RCT 来确定更好的 OSF 治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/37abb0a1afb7/12903_2023_3488_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/142e899a9056/12903_2023_3488_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/0aeeda503eba/12903_2023_3488_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/964bca522166/12903_2023_3488_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/37abb0a1afb7/12903_2023_3488_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/142e899a9056/12903_2023_3488_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/0aeeda503eba/12903_2023_3488_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/964bca522166/12903_2023_3488_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/726a/10568776/37abb0a1afb7/12903_2023_3488_Fig4_HTML.jpg

相似文献

1
Drug treatment for oral submucous fibrosis: an update.口腔黏膜下纤维性变的药物治疗:最新进展。
BMC Oral Health. 2023 Oct 12;23(1):748. doi: 10.1186/s12903-023-03488-9.
2
Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: A meta-analysis of randomized controlled clinical trials.透明质酸酶联合皮质类固醇治疗口腔黏膜下纤维性变的疗效:一项随机对照临床试验的荟萃分析。
J Oral Pathol Med. 2020 Apr;49(4):311-319. doi: 10.1111/jop.13009. Epub 2020 Apr 5.
3
Comparative effectiveness of medicinal interventions for oral submucous fibrosis: A network meta-analysis.药用干预措施治疗口腔黏膜下纤维性变的疗效比较:网状 Meta 分析。
J Stomatol Oral Maxillofac Surg. 2023 Jun;124(3):101423. doi: 10.1016/j.jormas.2023.101423. Epub 2023 Feb 11.
4
Antioxidant treatments in patients with oral submucous fibrosis: A systematic review.口腔黏膜下纤维性变患者的抗氧化治疗:系统评价。
J Oral Pathol Med. 2024 Jan;53(1):31-41. doi: 10.1111/jop.13503. Epub 2023 Dec 28.
5
Efficacy of Lycopene in the Treatment of Oral Submucous Fibrosis: A Meta-analysis of Randomized Controlled Trials.番茄红素治疗口腔黏膜下纤维化的疗效:一项随机对照试验的荟萃分析。
J Evid Based Dent Pract. 2020 Dec;20(4):101471. doi: 10.1016/j.jebdp.2020.101471. Epub 2020 Jul 6.
6
Curcumin in the treatment of oral submucous fibrosis: a systematic review and meta-analysis of randomized controlled trials.姜黄素治疗口腔黏膜下纤维性变的系统评价和荟萃分析:随机对照试验研究。
Int J Oral Maxillofac Surg. 2024 Mar;53(3):239-250. doi: 10.1016/j.ijom.2023.11.005. Epub 2023 Dec 5.
7
A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.一项评估番茄红素和姜黄素对口腔黏膜下纤维化患者疗效的比较研究:一项随机临床试验。
Indian J Dent Res. 2018 May-Jun;29(3):303-312. doi: 10.4103/ijdr.IJDR_551_16.
8
Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial.番茄红素和姜黄素治疗口腔黏膜下纤维性变疗效的比较:一项随机对照试验。
Oral Dis. 2019 Jan;25(1):73-79. doi: 10.1111/odi.12947. Epub 2018 Aug 22.
9
Turmeric in the management of oral submucous fibrosis: A systematic review and meta-analysis.姜黄治疗口腔黏膜下纤维性变的疗效:系统评价和荟萃分析。
J Cancer Res Ther. 2021 Apr-Jun;17(2):327-335. doi: 10.4103/jcrt.JCRT_95_20.
10
Comparing efficacy of curcumin with other treatment modalities in oral submucous fibrosis management - A systematic review and meta-analysis.姜黄素与其他治疗方式在口腔黏膜下纤维化管理中的疗效比较——一项系统评价与荟萃分析
J Ayurveda Integr Med. 2024 Jul-Aug;15(4):100950. doi: 10.1016/j.jaim.2024.100950. Epub 2024 Jul 9.

引用本文的文献

1
Induction and characterization of oral submucous fibrosis model with different pathological stages in rats and mice.大鼠和小鼠不同病理阶段口腔黏膜下纤维化模型的诱导与表征
Sci Rep. 2025 Aug 24;15(1):31128. doi: 10.1038/s41598-025-16715-w.
2
Efficiency of turmeric, triphala and aloe vera in the treatment of oral submucous fibrosis.姜黄、三果木和芦荟治疗口腔黏膜下纤维化的疗效
Bioinformation. 2025 Apr 30;21(4):630-634. doi: 10.6026/973206300210630. eCollection 2025.
3
Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline.

本文引用的文献

1
Discovery of polymethoxyphenyl-pyridines bearing amino side chains as tubulin colchicine-binding site inhibitors.发现具有氨基侧链的多甲氧基苯基吡啶作为微管蛋白秋水仙碱结合位点抑制剂。
Bioorg Med Chem. 2022 Nov 1;73:117007. doi: 10.1016/j.bmc.2022.117007. Epub 2022 Sep 15.
2
Comparative Efficacy of Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review and Network Meta-Analysis.口腔黏膜下纤维化管理干预措施的比较疗效:一项系统评价与网状Meta分析
J Pers Med. 2022 Aug 1;12(8):1272. doi: 10.3390/jpm12081272.
3
Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer.
表没食子儿没食子酸酯抑制槟榔碱诱导的口腔黏膜下纤维化的胶原积累。
Front Pharmacol. 2025 Jan 31;16:1540559. doi: 10.3389/fphar.2025.1540559. eCollection 2025.
4
Curcumin Alleviates Arecoline-induced Oral Submucous Fibrosis via the FOSL1/MAPK8 Axis.姜黄素通过FOSL1/MAPK8轴减轻槟榔碱诱导的口腔黏膜下纤维化
Cell Biochem Biophys. 2025 Jun;83(2):2227-2236. doi: 10.1007/s12013-024-01633-x. Epub 2024 Dec 15.
5
A scientometric study on research trends and characteristics of oral submucous fibrosis.一项关于口腔黏膜下纤维化研究趋势与特征的科学计量学研究。
J Dent Sci. 2024 Jul;19(3):1834-1839. doi: 10.1016/j.jds.2024.05.006. Epub 2024 May 18.
6
-An Extensive Review Focused on Recent Studies.- 一项聚焦近期研究的全面综述。
Foods. 2024 Jul 8;13(13):2155. doi: 10.3390/foods13132155.
口腔潜在恶性疾病:病因、发病机制及向口腔癌的转变
Front Pharmacol. 2022 Apr 20;13:825266. doi: 10.3389/fphar.2022.825266. eCollection 2022.
4
Clinical Assessment of Efficacy of Omega 3 in Oral Submucous Fibrosis Patients - A Randomized Controlled Trial.临床评估欧米伽 3 对口腔黏膜下纤维性变患者疗效的随机对照试验。
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1185-1192. doi: 10.31557/APJCP.2022.23.4.1185.
5
Areca Nut and Oral Cancer: Evidence from Studies Conducted in Humans.槟榔与口腔癌:来自人体研究的证据。
J Dent Res. 2022 Sep;101(10):1139-1146. doi: 10.1177/00220345221092751. Epub 2022 Apr 22.
6
Epithelial Atrophy, Fibrosis and Vascularity Correlation with Epithelial Dysplasia in Oral Submucous Fibrosis, a Prospective Study.上皮萎缩、纤维化及血管化与口腔黏膜下纤维化上皮发育异常的相关性:一项前瞻性研究
J Microsc Ultrastruct. 2020 Nov 9;10(1):1-6. doi: 10.4103/JMAU.JMAU_36_20. eCollection 2022 Jan-Mar.
7
Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.口腔黏膜下纤维化的恶性转化率:一项系统评价与Meta分析
J Clin Med. 2022 Mar 24;11(7):1793. doi: 10.3390/jcm11071793.
8
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue.从世界卫生组织第五版头颈部肿瘤分类更新:口腔和活动舌肿瘤。
Head Neck Pathol. 2022 Mar;16(1):54-62. doi: 10.1007/s12105-021-01402-9. Epub 2022 Mar 21.
9
Correlation of Clinical Features in Oral Submucous Fibrosis: A 9-Year Retrospective Study.口腔黏膜下纤维性变的临床特征相关性:一项 9 年回顾性研究。
Ethiop J Health Sci. 2022 Jan;32(1):137-144. doi: 10.4314/ejhs.v32i1.15.
10
An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis.番茄红素和姜黄素在口腔白斑及口腔黏膜下纤维化中的作用概述。
Natl J Maxillofac Surg. 2021 Sep-Dec;12(3):316-323. doi: 10.4103/njms.njms_324_21. Epub 2021 Dec 13.